Literature DB >> 10647830

Mesothelioma--VATS biopsy and lung mobilization improves diagnosis and palliation.

M W Grossebner1, A A Arifi, M Goddard, A J Ritchie.   

Abstract

OBJECTIVES: Mesothelioma is an increasingly frequent malignancy in which diagnosis is often delayed and disease diagnosed at an advanced stage. Earlier diagnosis and therapeutic intervention that can control recurrent pleural effusion may improve outlook and survival.
METHODS: A prospective series of 25 patients in whom mesothelioma was suspected was referred for histological diagnosis by video assisted-thoracoscopy (VAT) after failure of other methods. At the same operative procedure drainage of pleural effusion, cytoreductive pleurectomy and lung mobilization was performed where possible. Complete follow-up was obtained.
RESULTS: All patients had a histological diagnosis (100%) from the material sent for biopsy. In 23 patients this was mesothelioma, in two patients chronic empyema. All patients undergoing drainage of effusion, cytoreductive pleurectomy and lung mobilization subsequently were diagnosed of having mesothelioma stages III to IV. Fifteen out of 21 who underwent lung mobilization had closure of the pleural space. Post operative air leak in this group was a mean of 5 days (2-12 days). Recurrent effusion occurred in only one patient. Eleven patients remain alive at 1-2 years post operation with no hospital admissions for recurrent pleural effusion. In the six out of 21 who did not have closure of the pleural space, one remained alive 9 months post surgery. Five died within 1-6 months of the procedure. The average number of further hospital admissions for repeat drainage of effusion was 3 (1-6).
CONCLUSIONS: VATs provides adequate tissue for histological diagnosis where other methods fail. At the same operative sitting it provides a therapeutic intervention that allows drainage of effusion cytoreductive pleurectomy and lung mobilization in a significant number of cases. Where the pleural space can be closed this results in significantly fewer hospital admissions and appears to improve quality of life and length of survival. The price is a longer hospital stay due to prolonged air leak.

Entities:  

Mesh:

Year:  1999        PMID: 10647830     DOI: 10.1016/s1010-7940(99)00323-1

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

Review 1.  [Video-assisted diagnostic thoracoscopy].

Authors:  T Bergmann; S Bölükbas; S Beqiri; J Schirren
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

Review 2.  A systematic review of lung-sparing extirpative surgery for pleural mesothelioma.

Authors:  Elaine Teh; Francesca Fiorentino; Carol Tan; Tom Treasure
Journal:  J R Soc Med       Date:  2011-02       Impact factor: 5.344

3.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

Review 4.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

5.  Laparoscopic diagnosis of pleural mesothelioma presenting with pseudoachalasia.

Authors:  Greta Saino; Davide Bona; Marco Nencioni; Barbara Rubino; Luigi Bonavina
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 6.  Malignant mesothelioma: current status and perspective in Japan and the world.

Authors:  Seiki Hasegawa; Fumihiro Tanaka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-07-08

Review 7.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

8.  Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Hedy L Kindler; Nofisat Ismaila; Samuel G Armato; Raphael Bueno; Mary Hesdorffer; Thierry Jahan; Clyde Michael Jones; Markku Miettinen; Harvey Pass; Andreas Rimner; Valerie Rusch; Daniel Sterman; Anish Thomas; Raffit Hassan
Journal:  J Clin Oncol       Date:  2018-01-18       Impact factor: 44.544

9.  Primary Pleural Melanoma: A Case Report and Literature Review.

Authors:  Kojin Murakami; Kazunori Tobino; Yoshikazu Yamaji; Ryunosuke Ooi; Miyuki Munechika; Yuki Enzan; Yuki Yoshimatsu; Kosuke Tsuruno; Hiromi Ide; Noriyuki Ebi
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

10.  Probe-based confocal laser endomicroscopy for pleural malignancies diagnosis.

Authors:  Olivier Bonhomme; Vincent Heinen; Nancy Detrembleur; Jean-Louis Corhay; Renaud Louis; Bernard Duysinx
Journal:  Respirology       Date:  2020-10-01       Impact factor: 6.424

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.